KLK3 and prostate carcinoma: The basis for the observed decrease in the PSA secretion from these metastatic prostate cancer cell lines represents a genistein-induced multirange inhibition of the PSA gene and protein expression (Davis et al., 2000[34]) (Figure 1(Fig. 1)).